Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

Roche trumpets APHINITY data, but did it hit the mark?

Roche trumpets APHINITY data, but did it hit the mark? One year of adjuvant therapy with Perjeta plus Herceptin and chemotherapy can cost upwards of $150, 000, roughly twice the cost of Herceptin alone. ... A large chunk of Perjeta's $5bn sales forecast has been attributed to adjuvant use alongside Herceptin

FDA panel backs Puma's breast cancer drug, with reservations

FDA panel backs Puma's breast cancer drug, with reservations trial of Herceptin plus Perjeta (pertuzumab), which if positive could end up replacing Herceptin alone as the go-to adjuvant therapy for HER2-positive breast cancer.

A new decade of disruption: meeting the biosimilar challgenge

A new decade of disruption: meeting the biosimilar challgenge High price tags have seen a string of rejections for routine NHS use by the UK watchdog NICE, including cancer MAbs Avastin (bevacizumab), Kadcyla (ado-trastuzumab emtansine) and Perjeta (pertuzumab).

Mylan deal with Roche clears path to biosimilar Herceptin launch

Mylan deal with Roche clears path to biosimilar Herceptin launch A recent forecast suggested Herceptin will be particularly resilient, still near-$4bn product in 2022, helped by combination use with Roche's newer HER2 drug Perjeta (pertuzumab) which grew 26% to

NICE backs Roche’s Perjeta for routine NHS use

NICE backs Roche’s Perjeta for routine NHS use Roche's Perjeta is on track to become the first new breast cancer drug available to NHS patients for nearly a decade after NICE backed it in draft guidance. ... Given in combination with Herceptin (trastuzumab) and docetaxel, Perjeta (pertuzumab) was

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...
APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...

Infographics